Deepbridge are finalists two Growth Investor Awards
Deepbridge Capital is a finalist for 2 awards at the upcoming Growth Investor 2022 Awards, taking place Thursday, 24th November 2022 at London Hilton on Park Lane.
Deepbridge Capital is a finalist for 2 awards at the upcoming Growth Investor 2022 Awards, taking place Thursday, 24th November 2022 at London Hilton on Park Lane.
Touch Biometrix, an investee company within the Deepbridge Technology Growth EIS portfolio, has announced a successful Series B funding round, with plans to launch a FAP60 fingerprint biometric sensor as the first prodct utilising its thin transistor film (TFT) technology with 'active pixels'.
Sky Medical Technology Ltd., an investee company within the Deepbridge Technology Growth EIS portfolio, announced further U.S. Food and Drug Administration (FDA) 510(k) clearance to market the new (W3) geko™ device variant, for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency and/or ischemia.
RDVault, an investee company within the Deepbridge Life Sciences EIS portfolio, has won Tech Nation's fourth Rising Stars competition, which recognises the best early-stage technology scale-ups across the UK.